The Bonnie J. Addario Lung Cancer Foundation
The Lung Cancer Foundation's

LungBlog

An up-to-the-minute dose of health and hope for lung cancer

Bonnie Addario in UCSF Lab
 

OSI Pharmaceutical Starts New Tarceva Lung Cancer Trial

TarcevaOSI Pharmaceuticals Inc. (OSIP) said it will start a Phase III study of its Tarceva drug as a targeted adjuvant treatment for certain non-small-cell lung-cancer patients who have undergone surgery.

This entry was posted on Thursday, September 21st, 2006 at 9:33 am and is filed under Research, Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

« Westin Unveils ‘’Renewal Talisman'’ to Support Smoke-Free Living
New Test Can Catch Some Lung Cancer Cases »

Leave a Reply